Achieve Life Sciences, Inc. (ACHV)
7.84
-0.65
(-7.66%)
USD |
NASDAQ |
Sep 08, 16:00
7.90
+0.06
(+0.77%)
Pre-Market: 08:08
Achieve Life Sciences Debt to Equity Ratio : -1.018 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.018 |
| March 31, 2026 | 1.400 |
| December 31, 2025 | 0.695 |
| September 30, 2025 | 0.2962 |
| June 30, 2025 | 0.239 |
| March 31, 2025 | 0.969 |
| December 31, 2024 | 0.4765 |
| September 30, 2024 | 0.3138 |
| June 30, 2024 | 0.4173 |
| March 31, 2024 | 0.3477 |
| December 31, 2023 | -11.55 |
| September 30, 2023 | 4.031 |
| June 30, 2023 | 1.632 |
| March 31, 2023 | 37.21 |
| December 31, 2022 | 1.951 |
| September 30, 2022 | 15.12 |
| June 30, 2022 | 1.177 |
| March 31, 2022 | 0.7106 |
| December 31, 2021 | 0.5347 |
| September 30, 2021 | 0.0027 |
| June 30, 2021 | 0.0027 |
| March 31, 2021 | 0.0042 |
| December 31, 2020 | 0.0045 |
| September 30, 2020 | 0.0087 |
| June 30, 2020 | 0.0189 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.021 |
| December 31, 2019 | 0.0201 |
| September 30, 2019 | 0.0504 |
| June 30, 2019 | 0.0396 |
| March 31, 2019 | 0.049 |
| December 31, 2018 | 0.0015 |
| September 30, 2018 | 0.0018 |
| June 30, 2018 | 0.0018 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.0034 |
| September 30, 2017 | 0.0044 |
| June 30, 2017 | 0.0052 |
| March 31, 2017 | 0.0055 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.0027 |
| December 31, 2015 | 0.0042 |
| September 30, 2015 | 0.0044 |
| June 30, 2015 | 0.0065 |
| March 31, 2015 | 0.006 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Anika Therapeutics, Inc. | 0.1839 |
| Perspective Therapeutics, Inc. | 0.0122 |
| MiMedx Group, Inc. | 0.0797 |
| ProText Mobility, Inc. | 0.0003 |
| ABVC BioPharma, Inc. | 0.2807 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 190.44M |
| Total Liabilities (Quarterly) | 205.12M |
| Shareholders Equity (Quarterly) | -14.68M |
| Current Ratio | 0.9526 |
| Net Debt Paydown Yield | -0.15% |